PACS Group, Inc. (PACS)
| Market Cap | 5.93B +300.5% |
| Revenue (ttm) | 5.43B +22.2% |
| Net Income | 243.77M +393.3% |
| EPS | 1.56 +391.8% |
| Shares Out | 158.27M |
| PE Ratio | 24.09 |
| Forward PE | 15.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 840,456 |
| Open | 39.38 |
| Previous Close | 39.65 |
| Day's Range | 37.47 - 39.53 |
| 52-Week Range | 7.50 - 43.08 |
| Beta | -0.03 |
| Analysts | Strong Buy |
| Price Target | 47.00 (+25.4%) |
| Earnings Date | May 11, 2026 |
About PACS
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.
Financial Performance
In 2025, PACS Group's revenue was $5.29 billion, an increase of 29.32% compared to the previous year's $4.09 billion. Earnings were $191.54 million, an increase of 243.51%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for PACS stock is "Strong Buy." The 12-month stock price target is $47.0, which is an increase of 25.40% from the latest price.
News
Pacs Group price target raised to $48 from $42 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised the firm’s price target on Pacs Group (PACS) to $48 from $42 and keeps an Outperform rating on the shares after the company reported earnings.
PACS Group Earnings Call Transcript: Q1 2026
Q1 2026 saw double-digit revenue and net income growth, record occupancy, and strong operational execution, prompting a $50M increase in full-year Adjusted EBITDA guidance. The company remains focused on disciplined capital allocation, M&A, and quality improvement, with robust liquidity and a new share repurchase program.
Pacs Group reports Q1 EPS 50c, consensus 41c
Reports Q1 revenue $1.42B, consensus $1.36B. Reports Q1 adjusted EBITDA $170.4M vs. $97.6M last year.
Pacs Group raises FY26 adjusted EBITDA view to $605M-$625M from $555M-$575M
16:32 EDT Pacs Group (PACS) raises FY26 adjusted EBITDA view to $605M-$625M from $555M-$575M
PACS Group, Inc. Reports First Quarter 2026 Results
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...
PACS Group Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...
Pacs Group acquires operations of post-acute care facility in Alaska
Pacs Group (PACS) announced that independently operated subsidiaries of the company have acquired the operations of the post-acute care facility Ridgeway Senior Living in Anchorage, Alaska. As part of...
PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced that independently operated subsidiaries of the Company have acquired the operations of the pos...
Pacs Group co-founder, CFO Mark Hancock to retire
Pacs Group (PACS) announced the planned retirement of co-founder and CFO Mark Hancock on June 30, 2026. “When Mark and I first began discussing the idea that would become PACS…
Pacs Group names Carey Hendrickson CFO
Pacs Group (PACS) announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Hendrickson brings to PACS nearly four decades of financial leadership spa...
PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson...
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the planned retirement of Mark Hancock ...
PACS Group Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference
The organization reported record growth in 2025, driven by a mission-focused model, high occupancy, and strong financials. Despite ongoing government investigations, leadership emphasized operational strength, robust M&A opportunities, and optimistic guidance for 2026.
PACS Group, Inc. to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Patrick H. Conway, M...
Pacs Group price target raised to $42 from $40 at Oppenheimer
Oppenheimer raised the firm’s price target on Pacs Group (PACS) to $42 from $40 and keeps an Outperform rating on the shares following the company’s Q4 results and 10-K. Following…
Pacs Group price target raised to $44 from $42 at UBS
UBS raised the firm’s price target on Pacs Group (PACS) to $44 from $42 and keeps a Buy rating on the shares.
Pacs Group selloff following Q4 results may be overdone, says RBC Capital
Shares of Pacs Group (PACS) fell 11% despite strong Q4 results and 2026 guidance ahead of expectations, as investors focused on perceived organic growth concerns and acquisition-related dilution, RBC ...
Pacs Group price target raised to $52 from $47 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on Pacs Group (PACS) to $52 from $47 and keeps an Outperform rating on the shares. The firm is positive…
PACS Group Earnings Call Transcript: Q4 2025
Record 2025 results driven by strong integration, occupancy, and clinical quality, with revenue up 29% and adjusted EBITDA reaching $505M. 2026 guidance targets 8% revenue and 12% EBITDA growth, supported by disciplined acquisitions and a robust pipeline.
Pacs Group reports Q4 adjusted EBITDA $142.1M
Reports Q4 revenue $1.36B, consensus $1.30B. The company said, “We’re pleased with our overall 2025 results, which reflect our commitment to exceptional patient care, superb quality, consistent operat...
Pacs Group sees 2026 revenue $5.65B-$5.75B, consensus $5.36B
Sees 2026 adjusted EBITDA $555M-$575M. The company said, “As of today, PACS‘s growing portfolio comprises 323 healthcare operations across 17 states. PACS owns 56 facilities and holds 38 purchase opti...
PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United State...